TENIPOSIDE (VM-26), AN OVERLOOKED HIGHLY-ACTIVE AGENT IN SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL IN UNTREATED PATIENTS

被引：95
作者：
BORK, E
HANSEN, M
DOMBERNOWSKY, P
HANSEN, SW
PEDERSEN, AG
HANSEN, HH
机构：
[1] BISPEBJERG HOSP,DEPT INTERNAL MED C,DK-2400 COPENHAGEN NV,DENMARK
[2] HERLEV HOSP,DK-2730 HERLEV,DENMARK
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 04期
关键词：
D O I：
10.1200/JCO.1986.4.4.524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：524 / 527
页数：4
相关论文
共 8 条
[1]  
ISSELL BF, 1982, CANCER CHEMOTH PHARM, V7, P73
[2]  
PEDERSEN AG, 1983, CANCER TREAT REV, V10, P245, DOI 10.1016/0305-7372(83)90013-0
[3]  
PEDERSEN AG, 1984, CANCER TREAT REP, V68, P1289
[4]  
ROED H, 1985, P AM ASSOC CANC RES, V26, P1315
[5]   VM26 (NSC-122819) - CLINICAL-STUDY IN ADVANCED CANCER OF LUNG AND OVARY [J].
SAMSON, MK ;
BAKER, LH ;
TALLEY, RW ;
FRAILE, RJ .
EUROPEAN JOURNAL OF CANCER, 1978, 14 (12) :1395-1399
[6]  
SMITH IE, 1985, CANCER TREAT REP, V69, P43
[7]  
WOODS RL, 1979, CANCER TREAT REP, V63, P2011
[8]  
1979, WHO HDB REPORTING RE, P14
1